Small Molecule Drug Discovery
- 01Possession of a unique library of single compounds not previously reported
- 02Secured lead compounds that inhibit viral replication and infectious diseases
- 03Optimized creation of small molecules derived from lead compounds for clinical trial applications
- 04Discovery of new drugs through efficacy and safety evaluation of small molecules
RNA Therapeutics
- 01Development of an RNA therapeutics platform based on biologics
- 02Holder of the world’s only technology for LncRNA-based antiviral and antineoplastic therapeutics
- 03Development of therapeutics capable of simultaneously blocking viral replication and infectious diseases
- 04Discovery of new drugs through efficacy and safety evaluation
- 05GLP and GMP-compliant facility
RNA Editing Therapy for Emerging &
Re-emerging Viruses
- 01Development of RNA virus treatments utilizing CRISPR-Cas13b mRNA editing therapeutics
- 02Establishment of a major target gene library for RNA viruses
- 03Development of a therapeutic platform capable of rapid response to emerging and re-emerging viruses
- 04Development of Cas13b mRNA & crRNA delivery technology to target cells and tissues
Development of Primary Human Hepatocytes & Humanized Mouse Model
- 01Development of primary human hepatocytes for researching hepatitis B/C virus infection
- 02Cultivation technology for primary human hepatocytes that maintain the same characteristics as in humans
- 03Development of a humanized mouse model by transplanting with primary human hepatocytes
- 04Research and development of therapeutics, antineoplastic agents, vaccines, liver toxicity evaluation studies, and clinical surrogate models
